We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M Turnover 44%
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+23.45%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$208M
AUM Growth
+$24.2M
Cap. Flow
+$7.64M
Cap. Flow %
3.66%
Top 10 Hldgs %
36.52%
Holding
103
New
33
Increased
10
Reduced
10
Closed
44
Avg Time Held Equity + Options
0.2 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0 years
Avg Time Held Equity only
0.2 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0.1 years

Sector Composition

Rank Sector Weight
1 Healthcare 74.72%
2 Miscellaneous 23.48%
3 Technology 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GILD icon
1
CALL
Gilead Sciences
GILD
$206B
$11.8M 5.65%
+125,000
New +$12.9M
2014 Q4
0 quarters
ZBH icon
2
Zimmer Biomet
ZBH
$19.1B
$9.8M 4.69%
88,786
+37,286
+72% +$3.93M
2014 Q3
1 quarter
SYK icon
3
CALL
Stryker
SYK
$118B
$9.43M 4.53%
+100,000
New +$8.87M
2014 Q4
0 quarters
IONS icon
4
CALL
Ionis Pharmaceuticals
IONS
$4.43B
$9.26M 4.44%
+150,000
New +$7.4M
2014 Q4
0 quarters
ADVM icon
5
DELISTED
Adverum Biotechnologies
ADVM
$6.75M 3.24%
12,500
+7,500
+150% +$2.89M
2014 Q3
1 quarter
WMGI
6
DELISTED
Wright Medical Group
WMGI
$6.31M 3.03%
+235,000
New +$6.88M
2014 Q4
0 quarters
GILD icon
7
Gilead Sciences
GILD
$206B
$6.13M 2.94%
+65,000
New +$6.72M
2014 Q4
0 quarters
PBYI icon
8
Puma Biotechnology
PBYI
$364M
$5.68M 2.72%
30,000
+25,000
+500% +$5.55M
2013 Q4
4 quarters
AVDL
9
DELISTED
Avadel Pharmaceuticals
AVDL
$5.57M 2.67%
+325,000
New +$4.64M
2014 Q4
0 quarters
CPHD
10
DELISTED
Cepheid
CPHD
$5.41M 2.6%
+100,000
New +$5.06M
2014 Q4
0 quarters
ALNY icon
11
Alnylam Pharmaceuticals
ALNY
$19.3B
$5.34M 2.56%
55,000
+20,000
+57% +$1.85M
2014 Q2
2 quarters
LJPC
12
DELISTED
La Jolla Pharmaceutical
LJPC
$5.28M 2.53%
+286,053
New +$3.4M
2014 Q4
0 quarters
ASRT icon
13
DELISTED
Assertio
ASRT
$4.83M 2.32%
5,000
+3,000
+150% +$2.74M
2013 Q4
4 quarters
DYAX
14
DELISTED
Dyax
DYAX
$4.57M 2.19%
+325,000
New +$4.07M
2014 Q4
0 quarters
AGN
15
DELISTED
Allergan plc
AGN
$4.5M 2.16%
17,500
+2,500
+17% +$625K
2014 Q2
2 quarters
ZLTQ
16
DELISTED
Zeltiq Aesthetics
ZLTQ
$4.47M 2.14%
160,000
-15,000
-9% -$391K
2014 Q3
1 quarter
NVRO icon
17
DELISTED
Nevro
NVRO
$4.45M 2.13%
+115,000
New +$3.62M
2014 Q4
0 quarters
PTCT icon
18
PTC Therapeutics
PTCT
$4.71B
$4.4M 2.11%
85,000
+35,000
+70% +$1.54M
2014 Q3
1 quarter
PTLA
19
DELISTED
Portola Pharmaceuticals
PTLA
$4.25M 2.04%
150,000
+35,000
+30% +$973K
2014 Q3
1 quarter
NUVA
20
DELISTED
NuVasive
NUVA
$4.24M 2.04%
90,000
+40,000
+80% +$1.67M
2014 Q3
1 quarter
INSY
21
DELISTED
Insys Therapeutics
INSY
$4.22M 2.02%
+200,000
New +$3.95M
2014 Q4
0 quarters
HZNP
22
DELISTED
Horizon Therapeutics
HZNP
$3.87M 1.86%
300,000
-125,000
-29% -$1.56M
2014 Q3
1 quarter
AIRM
23
DELISTED
Air Methods Corp
AIRM
$3.74M 1.8%
+85,000
New +$3.98M
2014 Q4
0 quarters
BMRN icon
24
BioMarin Pharmaceuticals
BMRN
$11.7B
$3.62M 1.74%
+40,000
New +$3.33M
2014 Q4
0 quarters
KITE
25
DELISTED
Kite Pharma
KITE
$3.46M 1.66%
+60,000
New +$2.53M
2014 Q4
0 quarters

Similar funds

Ghost Tree Capital's Q4 2014 Portfolio in Review

As of Q4 2014, Ghost Tree Capital held 103 positions worth $208M, up 13% from $184M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Ghost Tree Capital deployed $7.64M of net new capital in Q4 2014, opening 33 new positions and adding to 10 existing holdings. Its largest new stake was Wright Medical Group: 235,000 shares worth $6.31M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, up from 67% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was AtriCure, an estimated $2.57M trimmed.

  • Ghost Tree Capital's largest Q4 2014 buy was Wright Medical Group: 235,000 shares worth $6.31M.
  • Ghost Tree Capital added most to Puma Biotechnology in Q4 2014, an estimated $5.55M increase.
  • Ghost Tree Capital's biggest Q4 2014 reduction was AtriCure, cutting an estimated $2.57M.
  • Ghost Tree Capital fully exited Community Health Systems in Q4 2014, selling an estimated $5.48M.
  • Ghost Tree Capital's ten largest holdings make up 37% of its $208M portfolio in Q4 2014.
  • Ghost Tree Capital opened 33 new positions and closed 44 in Q4 2014.
  • Ghost Tree Capital's portfolio value rose 13% quarter-over-quarter to $208M.

Based on Ghost Tree Capital's 13F filing for Q4 2014, filed 17 Feb 2015.